A task force assembled by Nobel Prize winner Jennifer Doudna's Innovative Genomics Institute proposes a way to lower the multimillion-dollar price of innovative cell and gene therapies and make those treatments more accessible to more people.
The 30-person task force, which met for a year, said in a report that a "mixed organizational model" of an academic institution, a nonprofit medical research organization and a public benefit corporation could oversee fundraising and research, manage manufacturing…
